Effects of Tirofiban in Patients with Acute Myocardial Infarction and Diabetes Mellitus undergoing Primary Percutaneous Coronary Intervention.
Xiuying TangRunjun LiPublished in: Current vascular pharmacology (2023)
The administration of tirofiban before reperfusion therapy compared with after reperfusion therapy is more effective in reducing the hyperthrombotic load, thrombus aspiration, inflammatory factors, and cTNI and can effectively improve myocardial perfusion and heart function.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- acute coronary syndrome
- st elevation myocardial infarction
- coronary artery disease
- left ventricular
- coronary artery bypass grafting
- antiplatelet therapy
- cerebral ischemia
- heart failure
- stem cells
- atrial fibrillation
- type diabetes
- oxidative stress
- adipose tissue
- brain injury
- metabolic syndrome
- skeletal muscle
- glycemic control
- coronary artery bypass
- cell therapy
- subarachnoid hemorrhage